LIREMA, UAB - financials and debts

Company age: 30 y. 8 mo.

Update

Lietuvos ir Vokietijos LIREMA - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 4,501,455 5,932,991 7,128,369 10,160,985 12,305,136 14,627,296 18,131,228 20,196,300
Profit before tax 785,892 879,354 1,734,951 2,235,075 2,857,716 3,162,001 3,756,521 3,712,971
Net profit 785,892 915,535 1,728,654 2,230,970 2,811,030 3,137,632 3,760,765 3,751,875
Equity 4,387,844 5,242,845 6,846,196 4,578,408 3,389,621 4,719,998 5,456,133 6,208,035
Liabilities 1,411,888 1,508,375 2,510,553 4,318,249 5,169,912 6,432,484 5,172,892 5,501,984
Non-current assets 4,358,469 5,102,132 5,194,397 4,256,634 5,003,690 7,865,142 8,251,092 8,357,448
Current assets 1,626,450 1,825,919 4,314,048 4,799,089 3,730,918 3,589,908 2,695,107 3,465,244
Total assets 5,984,919 6,928,051 9,508,445 9,055,723 8,734,608 11,455,050 10,946,199 11,822,692
Taxes paid
STI taxes - - - - - 1,544,967 1,899,543 2,058,139
Social insurance contributions - - - - - 1,261,342 1,517,092 1,843,220
Financial indicators
Revenue change y/y +19.1% +31.8% +20.1% +42.5% +21.1% +18.9% +24.0% +11.4%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 13.1% 13.2% 18.2% 24.6% 32.2% 27.4% 34.4% 31.7%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 17.9% 17.5% 25.2% 48.7% 82.9% 66.5% 68.9% 60.4%
Profit margin Net profit margin. Shows the overall profitability of the company. 17.5% 15.4% 24.3% 22.0% 22.8% 21.5% 20.7% 18.6%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 17.5% 14.8% 24.3% 22.0% 23.2% 21.6% 20.7% 18.4%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 0.3 0.3 0.4 0.9 1.5 1.4 0.9 0.9
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 61,175 66,976 65,298 78,716 79,947 84,186 94,928 98,679

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Lietuvos ir Vokietijos LIREMA - Social security debts

The company had no debts to Sodra

Lietuvos ir Vokietijos LIREMA - VMI tax arrears

From To Overdue, €
2025-12-30 2025-12-30 2023.64
2025-12-23 2025-12-29 2020.0
2025-12-18 2025-12-22 2016.88
2025-05-17 2025-05-19 53.41
2025-05-01 2025-05-16 0.47
2025-04-30 2025-04-30 0.28
2025-04-16 2025-04-16 83.59
2025-04-09 2025-04-15 4.18
2025-04-02 2025-04-08 368.83
2025-03-28 2025-04-01 368.43
2025-03-22 2025-03-24 365.45
2025-01-22 2025-01-22 2238.65

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
LIREMA, UAB (code 110728268) is a Private Limited Liability Company active in medical specialists activities. In 2025, the company generated revenue of €20.20M, up 11.4% year on year and 38.1% over two years. Net profit remained stable at €3.75M, while profit margin eased to 18.6% from 20.7% in 2024 and 21.5% in 2023, indicating that profitability held up despite faster top-line growth. Over the 2023-2025 period, revenue rose from €14.63M to €18.13M and then to €20.20M, while net profit increased from €3.14M to €3.76M and then stayed broadly unchanged in 2025. Balance sheet strength improved, with equity rising to €6.21M in 2025 and liabilities at €5.50M against total assets of €11.82M. The equity ratio was 52.5% and debt-to-equity 0.89. Asset turnover reached 1.71x, ROE was 60.4% and ROA 31.7%. Revenue per employee was €99.0K, and profit per employee was €18.4K.